HomeInsights52 Week Low Stocks

Remus Pharmaceuticals Ltd 52 Week Low

Remus Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.3 Cr

Volume Transacted

()

stocks purchased

1.4 K

Stocks Traded

()

Last Updated on: Dec 12, 2024

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

YEARLOW

₹ 1200

Last updated on: Dec 12, 2024

Key Highlights

  • The 52 Week Low of Remus Pharmaceuticals Ltd is ₹ 1200 as of 12 Dec 24 .

Company Fundamentals for Remus Pharmaceuticals Ltd

No data available

Market Price of Remus Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 20242500
11 Dec 20242511.6
10 Dec 20242556.05
09 Dec 20242587.05
06 Dec 20242571.75
05 Dec 20242566.85
04 Dec 20242624.45
03 Dec 20242640
02 Dec 20242645.05
29 Nov 20242710.5

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Remus Pharmaceuticals Ltd News Hub

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

09 Nov 2024 16:57

News

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

07 Nov 2024 10:21

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 2024 15:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 2024 12:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 2024 10:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 2024 15:16

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Remus Pharmaceuticals Ltd

Why is it important to track the 52-week low of Remus Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Remus Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Remus Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Remus Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Remus Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Remus Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Remus Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Remus Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Remus Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Remus Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Remus Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Remus Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Remus Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions